CloudTag (CTAG:LN), the company that brings personal monitoring to the health, wellbeing and fitness markets, has given DirectorsTalk the latest results from its independent user tests, carried out and verified in collaboration with the Human Performance Unit at the Centre for Sports and Exercise Science, University of Essex.
CloudTag has been conducting key external user tests on CloudTag’s proprietary sensors, electrodes and algorithms to validate their accuracy. These User Tests have shown very positive results with heart rate tracking between 98% and 99% in comparison to a clinical ECG machine during walking and running activity. Energy expenditure (kilocalories) tracking results show correlation between 91% and 99% against the medical gold standard measurement, a CPX Metabolic Cart.
These results support the Company’s strategy of delivering highly accurate, medical grade technology to the consumer market. The external validation of CloudTag’s proprietary sensors and electrodes developed by the in-house technical team, and proprietary algorithms developed in collaboration with IMEC International, is a major milestone in the build up to CloudTag’s product launch. The Directors believe CloudTag will deliver the most accurate consumer wearable device to the market to-date.
Amit Ben-Haim, CloudTag CEO, comments: “I am delighted with the progress to date and the endorsement of our technology’s accuracy. These results validate CloudTag’s proprietary miniature electrodes and algorithms, which enhance sensor interoperability, delivering highly accurate metrics. We look forward to the planned launch of our product to the market at the Consumer Electronics Show in January 2016. “
